Marshall Wace North America’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1.65M | Sell |
46,260
-1,100,242
| -96% | -$39.3M | 0.01% | 759 |
|
|
2021
Q2 | $22.7M | Sell |
1,146,502
-1,553,621
| -58% | -$30.7M | 0.09% | 227 |
|
|
2021
Q1 | $62.8M | Buy |
2,700,123
+632,255
| +31% | +$14.7M | 0.26% | 86 |
|
|
2020
Q4 | $43M | Buy |
+2,067,868
| New | +$43M | 0.19% | 132 |
|
|
2018
Q4 | – | Sell |
-131,062
| Closed | -$1.29M | – | 1504 |
|
|
2018
Q3 | $1.29M | Buy |
+131,062
| New | +$1.29M | 0.01% | 567 |
|